RFK Jr. Will Order Mifepristone Probe, Unclear On EMTALA

By Jessica Karins / January 30, 2025 at 4:42 PM
Controversy over HHS secretary nominee Robert F. Kennedy Jr.’s varying stances on abortion are likely to continue after his appearances on Capitol Hill this week, during which he said that he would direct FDA and the National Institutes of Health (NIH) to further study the safety of the abortion drug mifepristone, that President Donald Trump hasn’t taken a position on the pill’s access, and that he didn’t know whether federal law requires hospitals to provide emergency abortions. RFK Jr. told...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.